Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amin Ghareyazi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Plos One|July 26, 2024
DeepDRA: Drug repurposing using multi-omics data integration with autoencodersTaha Mohammadzadeh-Vardin, Amin Ghareyazi, Ali Gharizadeh, et al.
Bioinformatics (Oxford, England)|June 24, 2024
HGTDR: Advancing drug repurposing with heterogeneous graph transformersAli Gharizadeh, Karim Abbasi, Amin Ghareyazi, et al.
Cancers|September 10, 2021
Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic CancerAmin Ghareyazi, Amir Mohseni, Hamed Dashti, et al.
Pharmacological Reviews|December 13, 2025
Computational drug design in the artificial intelligence era: A systematic review of molecular representations, generative architectures, and performance assessmentKarim Abbasi, Parvin Razzaghi, Ali Gharizadeh, et al.
BMC Bioinformatics|July 25, 2022
Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer typesAmin Ghareyazi, Amirreza Kazemi, Kimia Hamidieh, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Plos One|July 26, 2024
DeepDRA: Drug repurposing using multi-omics data integration with autoencodersTaha Mohammadzadeh-Vardin, Amin Ghareyazi, Ali Gharizadeh, et al.
Bioinformatics (Oxford, England)|June 24, 2024
HGTDR: Advancing drug repurposing with heterogeneous graph transformersAli Gharizadeh, Karim Abbasi, Amin Ghareyazi, et al.
Cancers|September 10, 2021
Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic CancerAmin Ghareyazi, Amir Mohseni, Hamed Dashti, et al.
Pharmacological Reviews|December 13, 2025
Computational drug design in the artificial intelligence era: A systematic review of molecular representations, generative architectures, and performance assessmentKarim Abbasi, Parvin Razzaghi, Ali Gharizadeh, et al.
BMC Bioinformatics|July 25, 2022
Pan-cancer integrative analysis of whole-genome De novo somatic point mutations reveals 17 cancer typesAmin Ghareyazi, Amirreza Kazemi, Kimia Hamidieh, et al.
Pageof 1